US Patent Issued to QYUNS THERAPEUTICS on July 28 for "Anti-human interleukin 23 monoclonal antibody and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,303, issued on July 28, was assigned to QYUNS THERAPEUTICS Co. LTD. (Jiangsu, China).

"Anti-human interleukin 23 monoclonal antibody and application thereof" was invented by Jiwan Qiu (Jiangsu, China), Yong Kong (Jiangsu, China), Wei Chen (Jiangsu, China), Huaiyao Qiao (Jiangsu, China), Zhihua Qiu (Jiangsu, China), Yiliang Wu (Jiangsu, China), Tao Chen (Jiangsu, China) and Meijuan Wu (Jiangsu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an anti-human interleukin 23 (hIL-23) monoclonal antibody and an application thereof. The anti-human interleukin 23 (hIL-23) monoclonal antibody comprises three heavy chain c...